In mid-March the Pennsylvania state House voted to legalize medical marijuana. If the Senate passes the bill and Gov. Tom Wolf signs it into law as he is expected to, it would make Pennsylvania the first state in the U.S. to allow medical marijuana as a treatment option for people with autism.
Quietly, with little fanfare or vocal opposition, the Drug Abuse Resistance Education program known as D.A.R.E. removed marijuana from its list of “gateway drugs” on its website. But that doesn’t necessarily mean D.A.R.E. no longer sees marijuana as a gateway drug, as some are reporting.
It’s a great time in Pennsylvania! The state House voted 149-43 to legalize medical marijuana, but it gets even better. If the bill is signed into law, cannabis would be a legal treatment option for autism, making Pennsylvania the first state to specifically include the condition.
Comedian and actress Whoopi Goldberg is the latest celebrity to endorse and invest in medical cannabis.
The post Whoopi Goldberg Launching Cannabis Products to Help Women Deal with Menstrual Pain appeared first on The Anti-Media.
Marijuana may help heal a lot – epilepsy, cancer, migraines, depression, and the list just keeps growing. But it’s not perfect. Using marijuana can mar your judgement, or so suggests the results of a recent study which found people who visit Colorado to partake in a little ganja wind up in emergency rooms more often than Coloradans.
Would you support this?
The post Los Angeles Wants to Tax Medical Marijuana Sales to Solve Homelessness appeared first on The Anti-Media.
Given the mounting evidence concerning marijuana’s healing potential and the fact that legalization in states has not spurred true conflict and only served to produce tax revenue, I think it’s about time for Congress to proactively reschedule marijuana. But will they listen?
Depression currently affects almost 15 million people in the US every year.
The post New Research Shows Cannabis Could Help with Depression, PTSD, Immune System, Weight appeared first on The Anti-Media.
Depression currently affects almost 15 million people in the US every year. Similar numbers can be found in Europe. Depression and anxiety disorders cost us approximately $42 billion annually, comprising a whopping third of the mental health bill of the country. Is it possible that simple cannabinoids in medical marijuana can help treat this debilitating and costly mental health condition? [1]
A 120-patient trial showed patients taking cannabis-based Epidiolex were able to reduce their convulsive seizures by 39 percent.
The post New Cannabis Drug Able to Reduce Seizures by 39% for Some Epilepsy Patients appeared first on The Anti-Media.
